Marc Pelletier

Company: Novartis AG
Job title: Associate Director
Seminars:
Targeting NLRP3 in Myelodysplastic Syndrome: Initial Results from Phase Ib Trial of DFV890 9:00 am
day: Conference Day One AM
Company: Novartis AG
Job title: Associate Director
day: Conference Day One AM